Form 8-K Tonix Pharmaceuticals For: Aug 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tonix Pharmaceuticals (TNXP) Misses Q2 EPS by 8c
August 10, 2015 7:24 AM EDTTonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
... More